Chronic urticaria
Pro Research Analysisby 
Searched over 200M research papers for "chronic urticaria"
Chronic Urticaria Overview and Epidemiology
Chronic urticaria (CU) is a skin condition marked by recurring wheals and sometimes angioedema, lasting more than six weeks. It affects about 1% of the global population, with most cases occurring in young and middle-aged women. The disease can persist for several years and often takes over a year before effective management is achieved, significantly impacting patients' quality of life and leading to high healthcare costs 158.
Classification and Subtypes of Chronic Urticaria
CU is generally divided into two main subtypes: chronic spontaneous urticaria (CSU), which occurs without identifiable triggers, and chronic inducible urticaria (CIndU), which is triggered by specific factors such as pressure, temperature, or sunlight. Some patients may experience both forms simultaneously. CIndU has definite, subtype-specific triggers, while CSU is more often associated with underlying immune mechanisms 168.
Pathogenesis: Immune, Inflammatory, and Neuropsychological Factors
The exact causes of CU are not fully understood, but research highlights the involvement of immune dysregulation, inflammation, and coagulation pathways. Mast cells and basophils play a central role by releasing histamine and other mediators, leading to the characteristic wheals and itching. About half of patients with "idiopathic" CU have histamine-releasing autoantibodies, supporting the concept of autoimmune urticaria 348.
Recent studies also emphasize the interplay between immune, neurological, and psychological factors. Chronic pruritus can lead to central and peripheral sensitization, while psychological stress, anxiety, and depression can worsen symptoms and disrupt the hypothalamic-pituitary-adrenal axis, further diminishing quality of life 59.
Diagnosis and Clinical Assessment
Diagnosis of CU is primarily clinical, based on the presence of wheals and/or angioedema for more than six weeks. Guidelines recommend a thorough patient history, physical examination, and limited routine laboratory testing to rule out other causes and identify potential triggers, especially in CIndU. Additional tests may be performed to exclude differential diagnoses or to identify underlying causes in CSU 178.
Impact on Quality of Life and Comorbidities
CU significantly impairs health-related quality of life, especially when associated with angioedema or when both CSU and CIndU are present. Patients often experience severe itching, sleep disturbances, sexual dysfunction, and limitations in daily, work, and social activities. Psychiatric comorbidities such as anxiety and depression are common, affecting over 30% of patients with CSU 5689.
Treatment Strategies and Challenges
The main goal of CU treatment is complete symptom control. Current guidelines recommend a stepwise approach, starting with second-generation H1-antihistamines as first-line therapy. For patients unresponsive to standard doses, higher doses, omalizumab (a biologic), or cyclosporine may be used. However, more than 25% of cases are resistant to antihistamines, and even advanced therapies only control the disease in about two-thirds of these patients. There is a need for novel treatments targeting specific immune pathways and mediators 1567+1 MORE.
Systemic Effects and Future Directions
While CU is primarily a skin disorder, there is some evidence suggesting possible systemic effects involving the cardiac, respiratory, gastrointestinal, and nervous systems. The clinical significance of these findings is not yet clear and warrants further research . Future studies should focus on identifying disease subtypes, biomarkers, and new therapeutic targets to improve outcomes for patients with chronic urticaria 18.
Conclusion
Chronic urticaria is a complex, often persistent condition with significant physical, psychological, and economic impacts. Advances in understanding its immune, neurological, and psychological underpinnings are shaping more effective diagnostic and treatment strategies. However, challenges remain, especially for patients with treatment-resistant disease, highlighting the need for ongoing research and a holistic approach to care 1568+1 MORE.
Sources and full results
Most relevant research papers on this topic